524164 logo

IOL Chemicals and Pharmaceuticals Limited Stock Price

BSE:524164 Community·₹39.2b Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

524164 Share Price Performance

₹133.60
36.18 (37.14%)
₹150.00
Fair Value
₹133.60
36.18 (37.14%)
10.9% undervalued intrinsic discount
₹150.00
Fair Value
Price ₹133.60
AnalystConsensusTarget ₹150.00

524164 Community Narratives

·
Fair Value ₹150 10.9% undervalued intrinsic discount

Automated API Facilities And EU REACH Will Expand Export Markets

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
₹150
10.9% undervalued intrinsic discount
Revenue
13.42% p.a.
Profit Margin
8.89%
Future PE
21.11x
Price in 2029
₹213.41

Trending Discussion

Updated Narratives

524164 logo

524164: Board Review And Updated Assumptions Will Shape A Balanced Outlook

Fair Value: ₹150 10.9% undervalued intrinsic discount
7 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
2 Rewards

IOL Chemicals and Pharmaceuticals Limited Key Details

₹23.2b

Revenue

₹14.9b

Cost of Revenue

₹8.3b

Gross Profit

₹6.9b

Other Expenses

₹1.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
4.69
35.87%
5.94%
7.3%
View Full Analysis

About 524164

Founded
1986
Employees
2891
CEO
Varinder Gupta
WebsiteView website
www.iolcp.com

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

Recent 524164 News & Updates

Narrative Update Jun 05

524164: Board Review And Updated Assumptions Will Shape A Balanced Outlook

Analysts have raised their price target for IOL Chemicals and Pharmaceuticals from ₹110 to ₹150, citing updated assumptions that reflect the latest views on discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2026.

Recent updates

No updates